Examining 10-year postop data on epi-off CXL for keratoconus, ectasia

,

Steven Greenstein, MD, reports on the 10-year postop data from an epi-off corneal collagen cross-linking treatment in keratoconus and ectasia patients.

Steven Greenstein, MD, of the Cornea and Laser Institute (Teaneck, NJ), reports on the 10-year postop data from an epi-off corneal collagen cross-linking treatment in keratoconus and ectasia patients who underwent laser refractive surgery.

Read the article: CXL effects remain generally stable 10 years post-treatment

See more ASCRS coverage